As of 2026-08-18, the Relative Valuation of Novacyt SA (ALNOV.PA) is (14.60) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.55 EUR, the upside of Novacyt SA based on Relative Valuation is -2778.0%.
The range of the Relative Valuation is (13.80) - (13.98) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 32.9x - 50.2x | 38.6x |
| Forward P/E multiples | 28.8x - 33.4x | 31.2x |
| Fair Price | (13.80) - (13.98) | (14.60) |
| Upside | -2631.3% - -2665.1% | -2778.0% |
| Date | P/E |
| 2026-08-14 | -1.29 |
| 2026-08-13 | -1.23 |
| 2026-08-12 | -1.32 |
| 2026-08-11 | -1.14 |
| 2026-08-10 | -1.10 |
| 2026-08-07 | -1.05 |
| 2026-08-06 | -1.04 |
| 2026-08-05 | -1.04 |
| 2026-08-04 | -1.02 |
| 2026-08-03 | -1.00 |
| 2026-07-31 | -1.02 |
| 2026-07-30 | -1.02 |
| 2026-07-29 | -1.05 |
| 2026-07-28 | -1.07 |
| 2026-07-27 | -1.07 |
| 2026-07-24 | -1.06 |
| 2026-07-23 | -1.07 |
| 2026-07-22 | -1.07 |
| 2026-07-21 | -1.07 |
| 2026-07-20 | -1.09 |
| 2026-07-17 | -1.09 |
| 2026-07-16 | -1.10 |
| 2026-07-15 | -1.00 |
| 2026-07-14 | -1.00 |
| 2026-07-13 | -0.98 |
| 2026-07-10 | -0.97 |
| 2026-07-09 | -0.98 |
| 2026-07-08 | -0.94 |
| 2026-07-07 | -0.96 |
| 2026-07-06 | -0.96 |
| 2026-07-03 | -0.98 |
| 2026-07-02 | -0.96 |
| 2026-07-01 | -0.97 |
| 2026-06-30 | -0.94 |
| 2026-06-29 | -0.92 |
| 2026-06-26 | -0.95 |
| 2026-06-25 | -0.96 |
| 2026-06-24 | -1.00 |
| 2026-06-23 | -0.93 |
| 2026-06-22 | -0.92 |
| 2026-06-19 | -0.95 |
| 2026-06-18 | -0.94 |
| 2026-06-17 | -0.97 |
| 2026-06-16 | -0.96 |
| 2026-06-15 | -0.98 |
| 2026-06-12 | -1.01 |
| 2026-06-11 | -0.98 |
| 2026-06-10 | -1.00 |
| 2026-06-09 | -1.03 |
| 2026-06-08 | -1.10 |